MedPath

Memantine Hydrochloride

These highlights do not include all the information needed to use Memantine Hydrochloride Oral Solution safely and effectively. See full prescribing information for Memantine Hydrochloride Oral Solution. Memantine Hydrochloride Oral Solution, for oral use Initial U.S. Approval: 2003

Approved
Approval ID

a7b76864-6de7-45f6-be5b-5ecfca811627

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 12, 2023

Manufacturers
FDA

Chartwell RX, LLC

DUNS: 079394054

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Memantine Hydrochloride

PRODUCT DETAILS

NDC Product Code62135-943
Application NumberANDA204033
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 12, 2023
Generic NameMemantine Hydrochloride

INGREDIENTS (9)

SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
MEMANTINE HYDROCHLORIDEActive
Quantity: 2 mg in 1 mL
Code: JY0WD0UA60
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Memantine Hydrochloride - FDA Drug Approval Details